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Abstract: Cellular senescence and aging result in a reduced ability to manage persistent types of
inflammation. Thus, the chronic low-level inflammation associated with aging phenotype is called
“inflammaging”. Inflammaging is not only related with age-associated chronic systemic diseases such
as cardiovascular disease and diabetes, but also skin aging. As the largest organ of the body, skin is
continuously exposed to external stressors such as UV radiation, air particulate matter, and human
microbiome. In this review article, we present mechanisms for accumulation of senescence cells
in different compartments of the skin based on cell types, and their association with skin resident
immune cells to describe changes in cutaneous immunity during the aging process.
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1. Introduction
As the aging process occurs, the ability of the human body to resolve inflammation
becomes significantly reduced, resulting in an imbalance between proinflammation and
anti-inflammation. This results in a chronic low-grade pro-inflammatory state known
as “inflammaging”, which accelerates age-related diseases, such as diabetes, heart dis-
eases, and even certain types of cancer [1]. It is driven by a systemic increase in multiple
pro-inflammatory cytokines and is significantly influenced by several extrinsic factors, in-
cluding UV radiation (UVR), air particulate matter (PM), and the microbiome [1]. Notably,
cellular senescence arises from intrinsic (proliferative exhaustion and telomere shortening)
and extrinsic stresses and by the activation of oncogenes [2]. Senescent cells exhibit an
altered secretome referred to as a senescence-associated secretory phenotype (SASP), which
secretes pro-inflammatory cytokines that considerably alter the skin microenvironment [3].
Cellular senescence can transiently occur in several physiological conditions during em-
bryogenesis and wound healing; by contrast, senescence due to the process of skin aging is
mainly a persisting permanent state [4]. In this review, we discussed the recent updates on
cellular senescence and inflammaging during the aging process of the skin. The emphasis
of this review lies on the comprehensive understanding of the cellular cross-talks among
the components of skin microenvironment with resident immune cells, in association with
external environmental stressors that cause skin aging (Figure 1).
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Figure 1. The schematic view of cellular cross-talk between skin microenvironment and inflammaging. An illustrative 
overview of the article showing the delicate signaling pathways from senescent skin microenvironments in association 
with external stressors, such as UVR, microbiome, and PM. α-MSH, α-melanocyte stimulating hormone; AhR, Aryl hy-
drocarbon receptor; AP-1, Activator protein 1; ATG, Autophagy related; CCL2, C-C motif chemokine ligand 2; CREB, 
Cyclic AMP-responsive element-binding protein; DCs, Dendritic cells; DNMT, DNA methyltransferase; ECM, Extracellu-
lar matrix; ERK, Extracellular signal-regulated kinase; ET, Endothelin; H2AX, H2A histone family member X; IGF, Insulin-
like growth factor; IL, Interleukin; JNK, c-Jun N-terminal kinase; LCs, Langerhans cells; LN, Lymph node; MAPKAPK2, 
MAP kinase Activated Protein Kinase 2; MAPKs, Mitogen-activated protein kinases; MITF, Microphthalmia-associated 
transcription factor; MMPs, Matrix metalloproteinases; MNPs, Mononuclear phagocytes; mTOR, Mammalian target of 
rapamycin; NF-κB, Nuclear factor kappa-light-chain-enhancer of activated B cells; PD-1, Programmed cell death protein 
1; PKA, Protein kinase A; PM, Particulate matter; POMC, Pro-opiomelanocortin; ROS, Reactive oxygen species; SASP, 
Senescence-associate secretory phenotype; SCF, Stem cell factor; SDF-1, Stromal cell-derived factor-1; TGF, Tumor growth 
factor; Th cells, T helper cells; TNF-α, Tumor necrosis factor- α; TRM, Tissue-resident memory T cell; UV, Ultraviolet light; 




Figure 1. The schematic view of cellular cross-talk between skin microenvironment and inflammaging. An illustrative
overview of the article showing the delicate signaling pathways from senescent skin microenvironments in association with
external stressors, such as UVR, microbiome, and PM. α-MSH, α-melanocyte stimulating hormone; AhR, Aryl hydrocarbon
receptor; AP-1, Activator protein 1; ATG, Autophagy related; CCL2, C-C motif chemokine ligand 2; CREB, Cyclic AMP-
responsive element-binding protein; DCs, Dendritic cells; DNMT, DNA methyltransferase; ECM, Extracellular matrix; ERK,
Extr cellular signal-regulated ki se; ET, Endothelin; H2AX, H2A histone family member X; IGF, Insulin-like growth factor;
IL, Interleukin; JNK, c-Jun N-terminal kinase; LCs, Langerha s cells; LN, Lymp ode; MAPKAPK2, MAP kinase Activated
Protein Kinase 2; MAPKs, Mitogen-activated protein kinases; MITF, Microphthalmia-associated transcription factor; MMPs,
Matrix metalloproteinases; MNPs, Mononuclear phagocytes; mTOR, Mammalian target of rapamycin; NF-κB, Nuclear
factor kappa-light-chain-enhancer of activated B cells; PD-1, Programmed cell death protein 1; PKA, Protein kinase A;
PM, Particulate matter; POMC, Pro-opiomelanocortin; ROS, Reactive oxygen species; SASP, Senescence-associate secretory
phenotype; SCF, Stem cell factor; SDF-1, Stromal cell-derived factor-1; TGF, Tumor growth factor; Th cells, T helper cells;
TNF-α, Tumor necrosis factor- α; TRM, Tissue-resident memory T cell; UV, Ultraviolet light; YBX-1, Y-Box Binding Protein 1.
2. Fibroblast Senescence
An emerging hypothesis postulates that fibroblast senescence is the main driver of the
skin aging process as the release of SASPs increase and the proliferation of cells is arrested
irreversibly [4]. Fibroblasts are the major type of cells that constitute the dermis layer of the
skin. They produce integral components of the extracellular matrix (ECM), such as colla-
gen [5]. During the skin aging process, the ECM undergoes dramatic structural alterations
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and degradation, resulting in aging phenotypes of dermal thinning and loss of elasticity
that eventually cause wrinkle formation [6]. Permanent senescence or skin aging can be
induced in nonreplicating (senescent) fibroblasts by both intrinsic and extrinsic stressors
that lead to the shortening of telomeres, mitochondrial dysfunction, and subsequent activa-
tion of the DNA damage response signaling pathway, leading to cell cycle arrest [7–11].
The subsequent increase in the number of senescent fibroblasts results in the production of
SASPs rich in pro-inflammatory cytokines, including interleukin (IL)-1, IL-6, IL-8, IL-18,
matrix metalloproteinases (MMPs), and a variety of other inflammatory chemokines [12].
These cytokines can induce c-Jun N-terminal kinase (JNK) and the transcription factor
activator protein (AP-1), which subsequently activate MMPs, resulting in the breakdown
of collagen and loss of elasticity, and consequently, wrinkle formation [4,13–15].
The acquired senescence-like phenotype in fibroblasts is indicated by the elevated
levels of the cyclin-dependent kinases, p16INK4a and p21, and the tumor protein p53, and
the expression of senescence-associated β-galactosidase (SA-β-gal), which are critically
influenced by UVR [2]. In vitro, ultraviolet B light (UVB)-exposed skin cell types, includ-
ing fibroblasts and keratinocytes, exhibit DNA damage and cell cycle arrest evidenced
by expression of senescence markers, such as increased SASPs, and decreased Lamin
B1 [16–18]. On the contrary, in vivo experiments showed that chronic low-dose exposure
to UVB resulted in the accumulation of DNA damage and reduced Lamin B1 expression in
senescent cells within the mouse epidermis, explicitly in the basal and suprabasal layers,
but not the dermis [19].
UVR also downregulates tumor growth factor (TGF)-β signaling pathway by acti-
vating AP-1 and p53 [20]. TGF-β is a cytokine that promotes ECM formation via the
Smad pathway, leading to the downregulation of MMPs and enhancement of ECM gene
expression. TGF-β signaling is one of the major pathways that induce type I procollagen
synthesis and secretion through connective tissue growth factor (CTGF). The impaired
TGF-β/SMAD3 signaling results in the reduction of CTGF-dependent type I collagen syn-
thesis while increasing MMP1-induced collagen degradation, leading to dermal thinning.
Thus, decreased TGF-β signaling by UVR critically contributes to wrinkle formation [21].
Moreover, TGF-β regulates the activation/induction of autophagy by increasing the
mRNA expression of Beclin1, autophagy-related gene (ATG)5, and ATG7 in a Smad- and
JNK-dependent manner [22]. Autophagy in dermal fibroblasts plays a crucial role in the
aging process and skin homeostasis under damaged conditions induced by external stimuli,
such as UVR and PM, by repairing cellular machineries [23]. A lack of autophagy results in a
hyper-inflammatory skin reaction caused by inflammasome activation, leading to increased
aging phenotypes. Interestingly, the autophagy system and the circadian clock counteract
tissue degeneration and support longevity in many organisms [24]. Hence, the aged dermal
fibroblasts exhibit impaired autophagic responses because of the reduced expression of the
period circadian regulator 2 and mini-chromosome maintenance 7 helicase, a transcriptional
repressor component of the circadian oscillator [23–25].
Dermal fibroblasts also release insulin-like growth factor (IGF)-1, which is essential
for the balanced regulation of epidermal cell proliferation and differentiation [4]. IGF-1
signaling in senescent fibroblasts is significantly decreased due to the enhanced production
of superoxide anions in the dysfunctional mitochondria of aging dermal fibroblasts [26].
The inhibition of the IGF-1 pathway not only suppresses collagen synthesis in the dermis,
but also leads to epidermal atrophy due to the increased accumulation of the DNA damage-
induced phosphorylated histone protein, γH2AX, and p16INK4a-positive epidermal cells [4].
In addition, mammalian target of rapamycin (mTOR) signaling in dermal fibroblasts
has been implicated in senescence through the regulation of SASPs. The inhibition of
mTOR suppresses SASPs by downregulating mitogen-activated protein kinase (MAPK)-
activated protein kinase 2 translation through the binding protein 4EBP1 [27]. Rapamycin,
an mTOR inhibitor, suppresses translation of the membrane-bound cytokine IL-1a, re-
sulting in the downregulation of IL-1a-induced secretion of inflammatory SASPs [28,29].
Moreover, mTOR signaling pathway regulates inflammaging by activating the nuclear
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factor kappa-light-chain-enhancer of activated B cells (NF-κB), which in turn increases
SASPs [1]. Reduced IL-1a by rapamycin diminishes NF-κB transcriptional activity, resulting
in decreased SASPs [29].
Mitochondrial dysfunction is another major driver in both intrinsic and extrinsic
skin aging [30]. In aging fibroblasts increasing concentrations of reactive oxygen species
(ROS) either drive DNA damage in the skin or enhance AP-1 and NF-κB-dependent
signaling pathways, leading to inflammaging [31]. A previous study in a superoxide
dismutase-deficient mouse model indicated that mitochondrial superoxide anions could
not be detoxified, hence they accumulated in the mitochondria of the fibroblasts resulting
in accelerated skin aging phenotypes [32]. These data showed that mitochondrial dysfunc-
tion and enhanced superoxide anion concentrations lead to fibroblast senescence, thus,
accelerating aging in connective tissue-rich organs, such as skin [4].
Persistent ROS-induced DNA damage drives cellular senescence and can be identified
by markers for DNA double-strand breaks, such as γH2AX, that are co-localized with
DNA damage checkpoint factors including p53-binding protein 1 (53BP1), mediator of
DNA damage checkpoint protein 1, and Nijmegen breakage syndrome 1 [33]. In addition,
the occurrence of telomere-associated DNA damage foci (TAF) has been used to detect
senescent cells and quantify tissue aging in situ [34,35]. Replicative senescent baboon skin
fibroblasts and skin tissues from aged baboons revealed increased TAF as indicated by
co-localization of 53BP1 and γH2AX on telomeric DNA [16,36]. Among the extrinsic factors
that cause ROS-induced oxidative DNA damage, tobacco extract triggered inflammaging
on skin fibroblasts in vitro, resulting in premature cell cycle arrest, secretion of cytokines
and MMPs, and downregulation of cell junction proteins [16]. The tobacco extract-exposed
fibroblasts also caused keratinocytes to lose their expression of E-cadherin, tight junction
proteins, ZO-1, and involucrin [37].
3. Keratinocyte Senescence
Due to the higher turnover rate of skin keratinocytes compared to fibroblasts, it has
been postulated that the impact of a senescent phenotype is limited in the epidermis. In
senescent keratinocytes, ECM production and cell adhesions are significantly downreg-
ulated [38]. Due to the chronic low-level inflammation in cellular aging, IL-1α secretion
is increased in keratinocytes from aged skin [39]. A previous study on age-dependent
variation in cytokines, chemokines, and biological analytes rinsed from the surface of
healthy human skin showed significantly decreased levels of epidermal growth factor,
fibroblast growth factor 2, IFN-α2, IL-1 receptor antagonist, HSA, keratin-6, and involucrin
in aged skin, whereas cortisol levels were increased [40]. Moreover, several novel stratum
corneum proteins related to chronic inflammation were upregulated in aged skin, including
ORM1, a plasma-binding protein involved in the transport of inflammatory mediators [41].
Several studies reported the expression of senescence markers (p16INK4a, p21, and
p53), SA-β-gal activity, and the loss of lamin B1 expression in human keratinocytes after
UVB exposure [28]. Nonetheless, skin tissues from the sun-protected areas of young
and aged donors showed that p16INK4a-positive cells were mainly melanocytes and not
keratinocytes in the epidermis [42]. Lamin B1, an intermediate filament protein expressed in
all somatic cells, is downregulated in UV-induced senescent cells in vitro [19,43,44]. Wang
et al. described that the co-staining of lamin B1 with keratinocyte differentiation markers
revealed the accumulation and clearance of senescent cells in epidermal compartments
after the UV exposure [19].
The generation of ROS by UVR can lead to the phosphorylation and subsequent
activation of MAPKs; extracellular signal-regulated kinase (ERK), p38, and JNK [28]. These
molecules subsequently activate the c-Jun and c-fos components of AP-1. AP-1 increases the
expression of MMPs, which are highly expressed in UV-induced senescent keratinocytes in
culture and in the epidermis of irradiated human skin tissues [45]. Other SASPs elevated in
UV-induced senescent keratinocytes in culture include proinflammatory cytokines such as
TNF-α, IL-1α, IL-1β, and IL-6 [28]. SASPs from keratinocytes are not only under canonical
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transcriptional control of transcription factors including NF-κB, but also under translational
control of the RNA binding protein YBX1, which is significantly decreased in senescent
cells. This, in turn, promotes translation of SASP cytokines [46].
Air PM induces senescence in human skin cells, especially keratinocytes, via pro-
duction of ROS. PM is a mixture of particles suspended in the air, and a recent study on
PM showed that it could penetrate into the barrier disrupted skin, producing increased
IL-8 and MMP-1 from PM-treated keratinocytes [47]. Especially, PM2.5 with the aerody-
namic diameter less than 2.5µm, has been studied as the predictive indicator of cellular
stress [48]. PM2.5-induced senescence involves aryl hydrocarbon receptor (AhR)-induced
ROS production. Ryu et al. showed that PM2.5-AhR-ROS pathway results in keratinocyte
senescence by the epigenetic regulation of the expression of the senescence-associated
p16INK4a gene [49]. PM2.5-induced ROS results in a decrease in DNA methyltransferase
expression and an increase in DNA demethylase expression, leading to hypomethylation
of the p16INK4A promotor region, thus accelerating skin senescence [49].
Changes in the skin microbiome depend on environmental challenges, including
cumulative UV exposure, smoking, and pollution, which result in subsequent immunose-
nescence. These factors can influence skin physiology, including sebum production, im-
mune homeostasis, and alterations in pH and lipid composition [50,51]. Shibagaki et al.
established that diversification and alterations in the skin microbiome of older and younger
women in a healthy Japanese population have a significant effect on the aging process [52].
Wu et al. also confirmed that age-related alterations in skin microbiomes are body site-
dependent [53]. These authors found an age-associated decrease in Propionibacterium
abundance in the forehead, cheek, and forearm skin, which is probably related to the
decrease in sebaceous gland activity with aging [51,52]. Kim et al. studied age-related
changes in the skin microbiota of Korean women on the forehead and hands, and it was
revealed that the overall microbial distribution varied on the forehead, but was similar on
the hands across the age groups [54]. Their results showed that Firmicutes was more abun-
dant in the younger age group, while Bacteroidetes and Proteobacteria increased linearly with
aging. Notably, the alpha diversity indices increased significantly with age on the forehead
skin, indicating that the older people may be more susceptible to pathogenic invasions
due to the altered diversity of skin microbiota [54]. Thus, the imbalance of commensal
microbiome and increased abundance of pathogenic bacteria such as Proteobacteria might
lead to the aggravation of age-related skin disorders.
Additionally, the regulatory role of autophagy in the aging of fibroblasts and ker-
atinocytes has been thoroughly studied. A recent study suggested that the modulation
of autophage flux could regulate the skin pigmentation via melanosome degradation in
keratinocytes and melanocytes [54]. Melatonin, which plays a central role in cell apoptosis
and survival, induces autophagy, and protects keratinocytes from oxidative stress-induced
cell damage via the Sirtuin 1 pathway, whereas an autophagy inhibitor or small interfering
RNA-mediated ATG5 knockdown inhibits melatonin-mediated cell survival [55]. Caffeine,
for example, is known to protect keratinocytes from stress-triggered inflammaging by
activation of autophagy regulated by the adenosine A2a receptor, Sirtuin 3, and adenosine
monophosphate-activated protein kinase [56]. Hence, aging is closely associated with
a decline in autophagic capacity, which results in intracellular protein aggregation and
accumulation of dysfunctional mitochondria and ROS production [57]. This increase in
ROS production triggers intracellular danger-sensing multiprotein platforms called inflam-
masome, which regulates the secretion of pro-inflammatory IL-1β and IL-18 via activation
of caspase-1 [58].
4. Aging-Associated Pigmentation and Melanocyte Senescence
Keratinocytes are the main type of cells that signal the need for melanogenesis [28].
Upon UVR, keratinocytes secrete factors such as α-melanocyte stimulating hormone (α-MSH),
endothelin (ET)-1, and stem cell factor (SCF) in a p53-proopiomelanocortin-dependent manner,
which bind melanocortin 1, ETB, and c-kit receptors, respectively [28,59,60]. Microphthalmia-
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associated transcription factor (MITF) plays a critical role in the cascade process for the
induction of melanogenesis. UVR-induced DNA damage in keratinocytes activates p53
which initiates the transcription of proopiomelanocortin, which is subsequently cleaved
into peptides including α-MSH. Its binding to MC1R on melanocytes induces MITF which
activates melanogenesis [61]. ET-1 and SCF binding activates ERK/MAPK signaling,
thus stimulating melanogenesis [59,62]. While UVR strongly stimulates the production
of ET-1 and SCF in the epidermis, the fibroblasts isolated from photoaged skin produce a
greater amount of pro-melanogenic growth factors, including hepatocyte growth factor and
SCF [63]. Aging-associated pigmentation has also been reported to be driven by fibroblast
senescence through the repression of stromal cell-derived factor-1 expression [64]. A recent
study showed that the growth differentiation factor 15 increased in UVA-induced senescent
fibroblasts, and it increased melanocyte pigmentation through β-catenin [65].
In melanocytes, the α-MSH-induced protein kinase A/cyclic adenosine monophos-
phate response element-binding protein pathway and UVB-triggered mTOR signaling
(which subsequently inhibits autophagy) participate in upregulation of microphthalmia-
associated transcription factor activity, resulting in melanin production [23]. Interestingly,
autophagy is able to induce as well as to inhibit melanogenesis. The knockdown studies
of cellular autophagy proteins, such as microtubule-associated protein 1A/1B-light chain
3 (LC3), Beclin-1, and ATG5, in melanoma reversibly showed that the inhibition of LC3 can
reduce melanin and tyrosinase activity via decreased ERK activity [66]. Melanogenesis is a
tightly regulated process involving many intracellular molecules, including p53, which
reduces the level of tyrosinase when inhibited [28]. UVB irradiation of melanocytes ele-
vates the levels of p53, p21, and c-Fos and inhibits retinoblastoma phosphorylation. Thus,
repeated exposure of human melanocytes to UVB leads to increased pigmentation through
prolonged p53 expression [67].
A recent study in melanocyte senescence reported that melanocytes are the only epi-
dermal cells that truly express p16INK4A during aging on sun-protected skin [42]. Senescent
melanocytes also express markers of inflammaging, such as reduced high-mobility group
box 1 and dysfunctional telomeres [68]. Additionally, senescent melanocyte SASPs induce
telomere dysfunction in a paracrine manner and limit the proliferation of the surrounding
cells via activation of CXC chemokine receptor 3-dependent mitochondrial ROS [68]. Hence,
senescent melanocytes affect and impair basal keratinocyte proliferation and contribute to
epidermal atrophy [68].
Several dermatological diseases are associated with the accumulation of senescent
cells in the skin. Melasma, also known as melanotic hypermelanosis, is a chronic re-
lapsing hyperpigmentary disorder with a symmetric distribution primarily localized on
sun-exposed sites, generally the face, therefore presenting large dark patches [69]. Notably,
the demonstration of this chronic, acquired pigmentary disorder shows central molecular
traits, including evidence of oxidative stress, subclinical inflammation, and the presence of
numerous premature senescence markers in the skin [63,70,71]. The modification of dermal
senescent fibroblasts on melasma through their autocrine and paracrine activity has been
investigated. The damaged senescent p38/MAPK-positive cells in the upper dermis of
lesional hyperpigmented skin mediates stress-responses, showing its role in inflammaging
in melasma [63,72]. Moreover, the expression of MMP2 and MMP9 is significantly in-
creased when exposed to chronic UVR; this is possibly responsible for the disruption of the
basement membrane in melasma [73]. Interestingly, the rise in MMP2 and a reduction in
collagen IV correlates with the increase in melanocytes that protrude into the dermis [74,75].
These changes may enhance the transfer and accumulation of dermis-derived factors into
the epidermis, leading to excessive activation of dermal–epidermal interaction resulting
in melanogenesis [63].
The pathophysiology of hair graying is also been related to inflammaging of the hair
follicle, causing a combination of reduced ability to handle oxidative stress as well as
the loss of follicular melanocyte activity [76]. The impact from ROS and environmental
stressors is important in the aging process of melanocytes, and which may cause a direct
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melanocyte apoptosis [77]. The generation of melanin is itself an oxidative reaction; hence,
the accumulation of ROS and depletion of antioxidative enzymes, such as tyrosinase-related
protein-2 and catalase, have been reported as the contributing factors for hair graying [78].
5. Association between Skin Resident Immune Cells and Inflammaging
The skin is the outermost barrier organ which provides the first physical and immuno-
logical defense for our body. As an active immuno-protective organ, the skin contains
several types of immune cells including mononuclear phagocytes (MNPs) such as Langer-
hans cells (LCs), dendritic cells, macrophages, monocytes, and T cells [79]. Functional
cutaneous immune surveillance is gradually decreased as people age, which leads to an
increased susceptibility to skin infections and cancers [50]. Although the precise association
between the senescence of skin-resident immune cells and inflammaging has not been
properly understood thus far, recent growing evidence suggests that cellular crosstalk
between senescent stromal cells and immune cells results in the senescent phenotype of
the skin.
Among MNPs, LCs are the sole epidermal dendritic cells with self-renewal proper-
ties [80]. LCs are reduced in number and show a decreased cellular migration toward
the regional lymph nodes due to the lower expression level of IL-1β in aged skin [81,82].
The decreased migration of LCs potentially results in both suboptimal antigen-specific
T cell priming against pathogenic antigens and activation of regulatory T cells, which
contribute to the reduced immune surveillance and tolerance in older individuals [83]. In
addition, LCs in aged skin express a low amount of human beta-defensin-3, which is an
important antimicrobial peptide produced in response to a microbial challenge or skin
dysbiosis [82]. Our group has demonstrated that the homeostatic cellular network of LCs is
crucial for maintaining epidermal barrier integrity and function, which provides a possible
mechanism for the decreased skin barrier function in the elderly skin [84]. Consequently,
a reduced skin barrier function further promotes the chronic low-level inflammation in
response to environmental pollutants and triggers [47]. Macrophages and monocytes
are another major subset of MNPs in the skin which are recruited to the photoaged skin
induced by repeated exposure to UV [85]. Senescent fibroblasts produce several SASPs
including C-C motif chemokine ligand 2 (CCL2) which subsequently recruits prostaglandin
E2-producing monocytes and suppresses T cell immune responses [86]. Under the inflamed
conditions, skin-infiltrating monocytes are guided to differentiate into macrophages by cy-
tokine milieu containing a monocyte colony-stimulating factor [87], and these macrophages
release high levels of MMPs and ROS to degrade the dermal ECM and cause chronic in-
flammation [88]. These results strongly suggest that MNPs of the skin actively contribute
to inflammaging and promote the senescent phenotypes of the skin.
Quiescent skin harbors twice as many T cells as T cells in the circulation [89]. Those
skin-resident cells express memory and skin-resident phenotypes, so-called skin-resident
memory T cells [90]. It has been demonstrated that the aged skin has an increased CD4+
to CD8+ T cell ratio and regulatory T cell frequencies and decreased proliferation by
prostaglandin E2-producing monocytes [86,91,92]. In addition, repeated antigen stimula-
tion throughout aging leads to exhaustion of T cells, which are characterized by higher
expression of programmed cell death protein 1 (PD-1) and limits the effector function of
T cells in elderly [93]. It has been also proposed that senescent T cells produce a higher
level of Th2 and Th17 cytokines which might contribute to the higher incidence of bullous
pemphigoid in elderly [94–96]. However, one elegant study has shown no decline in T cell
density and the number of CD49A+CD8+ resident memory T cells in the aged skin [97].
Furthermore, antigen-specific proliferation to the microbial antigens and cytokine produc-
tion of IFN-γ and IL-17A was comparable between T cells derived from young and old
skins. Thus, further studies are necessary to conclude the cellular nature and functional
characteristics of senescent T cells of the skin to understand their role in inflammaging.
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6. Concluding Remark
Throughout a lifetime, skin is consistently exposed to inflammatory changes as a
result of external and internal stressors, such as UVR, air PM, and microorganisms. As
local inflammation and secretion of SASPs from skin microenvironment (consisted of ker-
atinocytes, melanocytes, and fibroblasts) increase, a shift toward cellular senescence trigger
inflammaging and the subsequent expressions of clinical skin aging phenotypes, such as
wrinkles. In this review, we summarized the most recent updates on the pathophysiology
of inflammaging of the skin, emphasizing on the cellular cross-talks among keratinocytes,
melanocytes, and fibroblasts, as well as their association with external environmental
stressors. We further discussed the association of these cells with skin resident immunes
cells, and showed the impact of inflammaging on impairment of adaptive immunity and
breakdown of skin ECM compartments. The development of novel strategies for blocking
the cross-talk between skin senescent cells and the immune cells will bring clinical benefits
of delaying inflammaging and promoting skin health and appearance.
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Abbreviations
4EBP 4E-binding protein 1
53BP1 p53-binding protein 1
α-MSH α-melanocyte stimulating hormone
AhR Aryl hydrocarbon receptor
AP-1 Activator protein 1
ATG Autophagy related
CCL2 C-C motif chemokine ligand 2
CREB Cyclic AMP-responsive element-binding protein




ERK Extracellular signal-regulated kinase
ET Endothelin
GF Growth factor
γH2AX Gamma H2A histone family member X
IGF Insulin-like growth factor
IL Interleukin
JNK c-Jun N-terminal kinase
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LC3 microtubule-associated protein 1A/1B-light chain 3
LCs Langerhans cells
MAPKAPK2 MAP kinase Activated Protein Kinase 2
MAPKs Mitogen-activated protein kinases
MDC1 Mediator of DNA checkpoint protein 1
MITF Microphthalmia-associated transcription factor
MMPs Matrix metalloproteinases
MNPs Mononuclear phagocytes
mTOR Mammalian target of rapamycin
NBS1 Nijmegen breakage syndrome 1 protein
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
ORM1 Orosomucoid 1 protein
PD-1 Programmed cell death protein 1
PKA Protein kinase A
PM Particulate matter
POMC Pro-opiomelanocortin
ROS Reactive oxygen species
SA-β-gal Senescence-associated β-galactosidase
SASP Senescence-associate secretory phenotype
SCF Stem cell factor
SDF-1 Stromal cell-derived factor-1
TAF Telomere-associated DNA damage foci
TGF Tumor growth factor
Th cell T helper cell
TNF-α Tumor necrosis factor- α
TRM Tissue-resident memory T cell
UVB Ultraviolet B light
UVR UV radiation
YBX-1 Y-Box Binding Protein 1
ZO-1 Zonula occludens-1
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